OGT and Emory Genetics Laboratory Develop New Molecular Arrays

11 Mar 2014
Sarah Thomas
Associate Editor

Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its range of research-validated CytoSure Molecular Arrays to investigate DNA copy number variation (CNV) underlying a variety of genetic disorders. Designed and optimized in collaboration with experts at Emory Genetics Laboratory (EGL; Atlanta, USA), the arrays are the ideal complement to DNA sequencing, providing a particularly powerful tool for investigating the variety of aberrations underlying genetic disorders. Professor Madhuri Hegde, Professor of Human Genetics at Emory University School of Medicine, will discuss the design and application of these arrays at the American College of Medical Genetics (ACMG) meeting on Thursday 27 March 2014.

Comparative genomic hybridization arrays (aCGH) are the gold-standard for CNV detection and the 60-mer oligonucleotide probes utilized by OGT’s aCGH platform have been shown to deliver superior CNV detection than alternative platforms. The expanded CytoSure Molecular Array portfolio now enables detection of CNV in genes associated with over 20 genetic disorders, including cardiovascular, inherited eye, intellectual disability and neuromuscular disorders, as well as a range of inherited cancers. In addition, genes covering each disorder can be combined to create bespoke custom arrays, or further customised by the addition of novel content to suit each individual research project.

For the easy extraction of meaningful results from aCGH data, all CytoSure Molecular Arrays are supplied with OGT’s class-leading CytoSure Interpret Software.

Utilizing highly targeted, exon-focused arrays has been shown to detect CNVs as small as 12 bp in size that were missed by targeted NGS.1 Whether used alone or alongside sequencing, CytoSure Molecular Arrays allow researchers to reliably investigate the role of CNV in a wide range of genetic disorders.
Register for OGT’s ACMG workshop to hear Professor Madhuri Hegde discuss the design and implementation of CytoSure Molecular Arrays at Emory Genetics Laboratory.

1. Detection limit of intragenic deletions with targeted array comparative genomic hybridization. BMC Genetics, 2013, 14:116

CytoSure™ Molecular Arrays

Oxford Gene Technology Ltd

Reliable detection of copy number changes for research into a range of genetic disorders. CytoSure Molecular Arrays are designed to accurately identify small intragenic copy number variations (CNVs) in genes associated with a variety of disorders. The content for each array has been designed and optimised in collaboration with leading molecular genetics experts at Emory University. In addition to pre-designed catalogue arrays, you can also utilise our extensive array design expertise to produce custom arrays matching your precise specifications.CytoSure™ Molecular Arrays Features: Accurate detection of copy number variation — a perfect complement to sequencing analysis Array content fully optimised and research-validated by Emory University Flexible array content and formats — create the ideal array for your needs Cost-effective processing — multiple molecular disorders can be included in a single array Easy data interpretation using optimised protocols and industry-leading CytoSure Interpret Software

(0)

Links

Tags

OGT and Emory Genetics Laboratory Develop New Molecular Arrays